The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,688,390 in first-year total cost, median $685,580.
Most frequent study sections
- HIV Immunopathogenesis and Vaccine Development Study Section[HIVD]3
Most frequent institutions
- CHILDREN'S MERCY HOSP (KANSAS CITY, MO)2
- CINCINNATI CHILDRENS HOSP MED CTR1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Natural killer cell regulation of the germinal center HIV neutralizing antibody response1R01AI147778-01A1 | BRADLEY, TODD CHRISTOPHER | CHILDREN'S MERCY HOSP (KANSAS CITY, MO), MO | $277,389 | HIVD |
| 2019 | Natural killer cell regulation of the germinal center HIV neutralizing antibody response1R56AI147778-01 | BRADLEY, TODD CHRISTOPHER | CHILDREN'S MERCY HOSP (KANSAS CITY, MO), MO | $725,421 | HIVD |
| 2019 | Targeting natural killer cells to enhance HIV vaccine responses1R01AI148080-01 | WAGGONER, STEPHEN N. | CINCINNATI CHILDRENS HOSP MED CTR, OH | $685,580 | HIVD |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.